Featured Research

from universities, journals, and other organizations

Two tests better than one to diagnose diabetes in overweight children

Date:
May 2, 2011
Source:
Children's Mercy Hospital and Clinics
Summary:
A new study found that the recommended blood test may not be enough to catch type 2 diabetes in overweight children, missing more than two-thirds of children at high-risk for the condition. Researchers found that performing two tests could dramatically reduce the risk of delayed diagnosis in overweight children.

A new study found that the recommended blood test may not be enough to catch type 2 diabetes in overweight children, missing more than two-thirds of children at high-risk for the condition. Researchers from Children's Mercy Hospital and Clinics found that performing two tests -- both the recommended hemoglobin A1C test and an oral glucose tolerance test -- could dramatically reduce the risk of delayed diagnosis in overweight children.

The findings were presented on April 30 at the Pediatric Academic Societies Annual Meeting in Denver.

The American Diabetes Association (ADA) revised clinical practice recommendations for type 2 diabetes screening in 2010 in an effort to encourage more screening and earlier diagnosis. While the oral glucose tolerance test was previously considered the gold standard for diabetes screening, diagnosis using hemoglobin A1C does not require a long fast beforehand, making it easier for patients.

"Our research indicates that special consideration may need to be given to overweight children being tested for diabetes," said lead researcher Ghufran S. Babar, MD, a pediatric endocrinologist at Children's Mercy. "Simply following the guidelines may not be enough to ensure these children get proper care."

The study evaluated the charts of 629 overweight and adolescent patients who had both tests. According to the findings, 40 percent of type 2 diabetes patients and 67 percent of high-risk patients identified through the oral glucose tolerance test would have shown a normal glycemic status if only the hemoglobin A1C test were used to diagnose them. Nearly nine out of ten patients (86 percent) had normal blood glucose levels according to their hemoglobin A1C results.

"Lifestyle changes and early treatment can help delay disease progression of diabetes," said Wayne Moore, MD, PhD, chief and medical director of the endocrine/diabetes section at Children's Mercy. "It is important that patients are diagnosed as early as possible for the best outcomes."


Story Source:

The above story is based on materials provided by Children's Mercy Hospital and Clinics. Note: Materials may be edited for content and length.


Cite This Page:

Children's Mercy Hospital and Clinics. "Two tests better than one to diagnose diabetes in overweight children." ScienceDaily. ScienceDaily, 2 May 2011. <www.sciencedaily.com/releases/2011/05/110502091958.htm>.
Children's Mercy Hospital and Clinics. (2011, May 2). Two tests better than one to diagnose diabetes in overweight children. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2011/05/110502091958.htm
Children's Mercy Hospital and Clinics. "Two tests better than one to diagnose diabetes in overweight children." ScienceDaily. www.sciencedaily.com/releases/2011/05/110502091958.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins